Neurological pupil index and its association with other prognostic tools after cardiac arrest: A post hoc analysis.


Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
10 2022
Historique:
received: 30 05 2022
revised: 18 07 2022
accepted: 23 07 2022
pubmed: 2 8 2022
medline: 5 10 2022
entrez: 1 8 2022
Statut: ppublish

Résumé

We evaluated the concordance of the Neurological pupil Index (NPi) with other predictors of outcome after cardiac arrest (CA). Post hoc analysis of a prospective, international, multicenter study including adult CA patients. Predictors of unfavorable outcome (UO, Cerebral Performance Category of 3-5 at 3 months) included: a) worst NPi ≤ 2; b) presence of discontinuous encephalography (EEG) background; c) bilateral absence of N20 waves on somatosensory evoked potentials (N20 A total of 269/456 (59 %) patients had UO and 186 (41 %) underwent MMM. The presence of myoclonus was assessed in all patients, EEG in 358 (78 %), N20 in 186 (41 %) and NSE measurement in 228 (50 %). Patients with discontinuous EEG, N20 In this study, NPi ≤ 2 had moderate to high concordance with other unfavorable outcome prognosticators of hypoxic-ischemic brain injury. This indicates that NPi measurement could be considered as a valid tool for coma prognostication after cardiac arrest.

Identifiants

pubmed: 35914656
pii: S0300-9572(22)00621-9
doi: 10.1016/j.resuscitation.2022.07.030
pii:
doi:

Substances chimiques

Phosphopyruvate Hydratase EC 4.2.1.11

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

259-266

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Lorenzo Peluso (L)

Department of Biomedical Sciences, Humanitas Huniversity, Pieve Emanuele, Milan, Italy; Department of Anaestesiology and Intensive Care, Humanitas Gavazzeni, Bergamo, Italy; Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: lorenzopeluso80@gmail.com.

Mauro Oddo (M)

Medical Directorate for Research, Education, Innovation, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Lausanne, Switzerland.

Andrea Minini (A)

Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Giuseppe Citerio (G)

School of Medicine and Surgery, University Milano Bicocca, Neuro-intensive Care Unit, San Gerardo Hospital, ASST-Monza, Monza, Italy.

Janneke Horn (J)

Department of Intensive Care, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Amsterdam Neurosciences, Amsterdam University Medical Centers, Amsterdam, the Netherlands.

Eugenio Di Bernardini (E)

Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Malin Rundgren (M)

Department of Clinical Sciences, Anesthesiology and Intensive Care Medicine, Skåne University Hospital, Lund University, Lund, Sweden.

Alain Cariou (A)

Intensive Care Unit, Hopital Cochin, Paris, France; Paris Descartes University, Paris, France.

Jean-Francois Payen (JF)

Department of Anesthesia and Critical Care, Grenoble Alpes University Hospital, Grenoble, France.

Christian Storm (C)

Department of Internal Medicine, Nephrology and Intensive Care, Charité-University, Berlin, Germany.

Pascal Stammet (P)

Department of Intensive Care Medicine, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.

Claudio Sandroni (C)

Department of Intensive Care Emergency Medicine and Anaesthesiology, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.

Fabio Silvio Taccone (FS)

Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH